Update on the Human Immunodeficiency Virus

Medecine et Maladies Infectieuses

Volumn 43, Issue 5, 2013, Pages 177-184

  Brun Vezinet F ^a   Charpentier, C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Genetic diversity; HIV; Resistance; Viral load

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT;

ENZYME LINKED IMMUNOSORBENT ASSAY; FETOMATERNAL TRANSFUSION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; NONHUMAN; PATHOGENICITY; POST EXPOSURE PROPHYLAXIS; PREVALENCE; PROTEIN ANALYSIS; RAPID DIAGNOSTIC ORIENTATION TEST; REVIEW; SEROLOGY; VIRAL TROPISM; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADULT; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MORBIDITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK; VIRAL LOAD; VIRAL TROPISM; WORLD HEALTH;

EID: 84878807022     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2013.03.001     Document Type: Review

References (16)

1. http://www.unaids.org/en/resources/campaigns/20121120_globalreport2012/.
2. Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F. Acute HIV-1 infection. N Engl J Med 2011, 364:1943-1954.
3. Buchbinder S. HIV epidemiology, testing strategies, and prevention interventions. Top HIV Med 2010, 18(2):38-44.
4. HIV diagnostic testing: evolving technology and testing strategies. Top Antivir Med 2011;19(1):18-22.
5. Dépistage de l'infection par le VIH en France, stratégies et dispositif de dépistage: Synthèse et recommandations (pdf, 338Ko)/HAS (Haute Autorité de Santé). - Octobre 2009.
6. Delaugerre C., Simon F. Les Trod: des outils pour le dépistage du VIH?. Feuillets de biologie 2012, 304.
7. Patel P., Mackellar D., Simmons P., Uniyal A., Gallagher K., Bennett B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170(1):66-74.
8. Rapport 2010: prise en charge médicale des personnes infectées par le VIH: rapport 2010, recommandation du groupe d'experts. La documentation française. Prise en charge des situations d'exposition au risque viral chez l'adulte: 350-362.
9. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1-166. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
10. Vandamme A.M., Camacho R.J., Ceccherini-Silberstein F., de Luca A., Palmisano L., Paraskevis D., et al. European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev 2011, 13(2):77-108.
11. Rapport 2010: prise en charge médicale des personnes infectées par le VIH: rapport 2010, recommandation du groupe d'experts. La documentation française. Résistance aux antirétroviraux; 251-264.
12. Chaix M.L., Descamps D., Wirden M., Bocket L., Delaugerre C., Tamalet C., et al. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France. AIDS 2009, 23(6):717-724.
13. Vandekerckhove LP, Wensing AM, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, et al. European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis;11(5):394-407.
14. Li J.Z., Paredes R., Ribaudo H.J., Svarovskaia E.S., Metzner K.J., Kozal M.J., et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. JAMA 2011, 305(13):1327-1335.
15. Hamers R.L., Smit P.W., Stevens W., Schuurman R., Rinke de Wit T.F. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 2009, 14(5):619-629.
16. Johnson V.A., Calvez V., Günthard H.F., Paredes R., Pillay D., Shafer R., et al. Update of the drug resistance mutations in HIV-1. Top Antivir Med 2011, 19(4):156-164.